CPT 86581 is referenced in 6 tracked payer policy changes from Harvard Pilgrim Health Care, Connecticut Medicaid (HUSKY Health), and 2 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 86581 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Point32Health (Harvard Pilgrim) is implementing extensive CPT code changes across multiple laboratory policies effective June 1, 2026, including removing 23 codes and adding 24 new codes across 11 different lab testing categories. A new prenatal testing policy for fetal aneuploidy is also being introduced.
Connecticut Medicaid is adjusting reimbursement rates for four clinical diagnostic laboratory codes (81517, 84393, 84394, 86581) effective retroactively to January 1, 2026, to comply with federal law requiring Medicaid payments not exceed Medicare rates. Code 81517 drops significantly from $352.38 to $123.33.
Connecticut Medicaid (CMAP) updated procedure codes and payment rates effective January 1, 2026, including significant rate reductions for lab codes 81517, 84393, 84394, and 86581. The system has processed automatic adjustments and claims will appear on March remittance advice with specific ICN codes.
Aetna considers FDA-approved pneumococcal conjugate vaccines (PCV15, PCV20, PCV21) and pneumococcal polysaccharide vaccine (PPSV23) medically necessary according to CDC ACIP recommendations for specified groups. Those groups include all children aged 2 through 59 months, children and adolescents who meet the listed risk-condition and catch-up criteria, adults 50 years of age or older who have not previously received a pneumococcal conjugate vaccine or whose vaccination history is unknown, and adults 19 through 49 years with listed underlying health conditions. Adults 65 years or older may receive PCV20 or PCV21 through shared clinical decision-making, or receive no additional pneumococcal vaccines. Aetna considers these vaccines experimental, investigational or unproven for other groups. Quantitation of Streptococcus pneumoniae antibody (IgG) is medically necessary to diagnose immunodeficiency syndromes in persons with recurrent bacterial infections and to assess eligibility for parenteral immunoglobulin replacement, and is experimental, investigational or unproven for other indications.
Aetna's pneumococcal vaccine policy considers the conjugate vaccines PCV15 (Vaxneuvance), PCV20 (Prevnar 20) and PCV21 (Capvaxive) medically necessary for the age and risk groups it lists, and PPSV23 (Pneumovax 23) for the groups in its selection criteria. Coverage follows the CDC's ACIP recommendations, including the dosing rules for children, adults 19 to 49 years with underlying conditions, and adults 50 years or older. Aetna considers these vaccines experimental, investigational or unproven for other groups, and considers quantitation of Streptococcus pneumoniae IgG antibody medically necessary only to diagnose immunodeficiency in persons with recurrent bacterial infections and to assess eligibility for parenteral immunoglobulin replacement.
Already effective July 1, 2025, Louisiana Blue accepts only the CAQH application for professional credentialing and recredentialing, and the Louisiana Standardized Credentialing Application was accepted for participating providers until June 30. Added codes in the Diagnostic and Therapeutic Services and Outpatient Procedure Services code ranges have effective dates of January 1, 2025 and April 1, 2025, including 15013, 15014, 38226 and 38227. For infusion therapy, the prior authorization must include all codes billed, including administration codes, or penalties will be applied to the claim.
Watch 86581
Get one email when a payer policy names 86581, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.
Get alerts for changes like this
Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.